CLASS II Device recall · Reported 29 Jan 2014 · FDA Enforcement Report

Pulmonary Hemi-Artery SG Used in heart surgery recalled by CryoLife

CryoLife is recalling Pulmonary Hemi-Artery SG Used in heart surgery, distributed in California. The recall was initiated on 22 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial No. 10119759, Model SGPH00
Quantity recalledOne

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0809-2014
FDA event ID
67182
Recalling firm
CryoLife, Kennesaw, GA
Classification
Class II
Status
Terminated
Recall initiated
22 Nov 2013
FDA classified
23 Jan 2014
Reported
29 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

22 Nov 2013Recall initiated by company
23 Jan 2014Classified by FDA+62 days
29 Jan 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Serological testing for the donor was performed with a blood sample that may have been hemodiluted due to the administration of normal saline to the donor prior to death.

Product as listed by the FDA

Pulmonary Hemi-Artery SG Used in heart surgery

Where it was distributed

US distribution in CA.

California

Questions about this recall

Why was it recalled?

Serological testing for the donor was performed with a blood sample that may have been hemodiluted due to the administration of normal saline to the donor prior to death.

Which lots are affected?

Serial No. 10119759, Model SGPH00

Where was it sold?

US distribution in CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from CryoLife

All 14

Other Other Medical Devices recalls

All 13,929